135 related articles for article (PubMed ID: 24709373)
1. Drug company drops case after EMA agrees to redactions in some documents to be published.
Dyer C
BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373
[No Abstract] [Full Text] [Related]
2. Europe's drug regulator opens vaults of clinical-trials data.
Abbott A
Nature; 2016 Oct; 538(7626):440. PubMed ID: 27786232
[No Abstract] [Full Text] [Related]
3. AbbVie considers harms to be commercially confidential information: sign a petition.
Gøtzsche PC
BMJ; 2013 Dec; 347():f7569. PubMed ID: 24366821
[No Abstract] [Full Text] [Related]
4. European ombudsman questions European Medicines Agency over AbbVie redactions.
Watson R
BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123
[No Abstract] [Full Text] [Related]
5. Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies.
Cohen K; Cormier JW; Davar MV
J Contemp Health Law Policy; 2013; 29(2):201-32. PubMed ID: 23837261
[No Abstract] [Full Text] [Related]
6. Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents.
Doshi P
JAMA Intern Med; 2013 Nov; 173(21):2009-11. PubMed ID: 23959623
[No Abstract] [Full Text] [Related]
7. NICE is urged to make drug companies supply all trial data.
O'Dowd A
BMJ; 2012 Dec; 345():e8294. PubMed ID: 23223692
[No Abstract] [Full Text] [Related]
8. Drug companies should release data from all trials of licensed drugs, say MPs.
Hawkes N
BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
[No Abstract] [Full Text] [Related]
9. Drug-company data vaults to be opened.
Cressey D
Nature; 2013 Mar; 495(7442):419-20. PubMed ID: 23538802
[No Abstract] [Full Text] [Related]
10. Neonatal drug trials: impact of EU and US paediatric regulations.
Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E
Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777
[No Abstract] [Full Text] [Related]
11. Putting GlaxoSmithKline to the test over paroxetine.
Doshi P
BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673
[No Abstract] [Full Text] [Related]
12. Glaxo agrees to post results of drug trials on web site.
Harris G
N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
[No Abstract] [Full Text] [Related]
13. Transparency campaigners welcome new rules for clinical trials in Europe.
Kmietowicz Z
BMJ; 2014 Apr; 348():g2579. PubMed ID: 24699321
[No Abstract] [Full Text] [Related]
14. European regulator is ordered not to release clinical study documents.
Kmietowicz Z
BMJ; 2013 May; 346():f2846. PubMed ID: 23641049
[No Abstract] [Full Text] [Related]
15. European regulator is urged to release data on drugs approved in past 10 years.
Kmietowicz Z
BMJ; 2013 Sep; 347():f5905. PubMed ID: 24081901
[No Abstract] [Full Text] [Related]
16. Direct-to-consumer drug information in Europe.
Ager B
Lancet; 2007 Mar; 369(9564):822. PubMed ID: 17350444
[No Abstract] [Full Text] [Related]
17. EU directive on clinical trials penalizes small sponsors.
Meldolesi A
Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
[No Abstract] [Full Text] [Related]
18. [Public access to the results of clinical trials with drugs: is this enough for practicing physicians and patients?].
Dal-Ré R
Med Clin (Barc); 2014 Aug; 143(4):180-4. PubMed ID: 24667112
[No Abstract] [Full Text] [Related]
19. The European Medicines Agency's plans for sharing data from clinical trials.
Groves T; Godlee F
BMJ; 2013 May; 346():f2961. PubMed ID: 23657192
[No Abstract] [Full Text] [Related]
20. Drug marketing exclusivity under United States and European Union law.
Junod V
Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
